Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy

Chest

Volumn 128, Issue 3, 2005, Pages 1201-1208

  Chambellan, Arnaud ^a   Chailleux, Edmond ^a   Similowski, Thomas ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Anemia; COPD; Erythropoietin; Hematocrit; Long term oxygen therapy; Survival

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 24944560972     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1201     Document Type: Article

References (41)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
2. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317:1309-1314
3. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895-902
4. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial; Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93:391-398
5. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981; 1:681-686
6. MacNee W, Wiggs B, Belzberg AS, et al. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989; 321:924-928
7. Wouters EF. Chronic obstructive pulmonary disease: 5. Systemic effects of COPD. Thorax 2002; 57:1067-1070
8. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150:1453-1455
9. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856-1861
10. Schonhofer B, Wenzel M, Geibel M, et al. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26:1824-1828
11. Schonhofer B, Bohrer H, Kohler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998; 53:181-184
12. Upchurch GR Jr, Proctor MC, Henke PK, et al. Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease. J Vasc Surg 2003; 37:594-599
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012
14. Chailleux E, Fauroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: a 10-year analysis of ANTADIR observatory. Chest 1996; 109:741-749
15. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123:1460-1466
16. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:1-100
17. World Health Organization. Nutritional anemias: report of a WHO scientific group. WHO Technical Report Series 405. Geneva, Switzerland: World Health Organization, 1968; 1-37
18. Baldwin EF, Cournand A, Richards DW. Pulmonary insufficiency: III. A study of 122 cases of chronic pulmonary emphysema. Medicine 1949; 28:201-210
19. Wilson RH, Borden C, Ebert RV. Adaptation to anoxia in chronic pulmonary emphysema. Arch Intern Med 1951; 88:581-585
20. Vanier T, Dulfano J, Wu C, et al. Emphysema, hypoxia and the polycthemic response. N Engl J Med 1963; 269:169-178
21. Cocking JB, Darke CS. Blood volume studies in chronic obstructive non-specific lung disease. Thorax 1972; 27:44-51
22. Renzetti AD Jr, McClement JH, Litt BD. The Veterans Administration Cooperative Study of Pulmonary Function: 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966; 41:115-129
23. Freedman M, Sutin D. Blood disorders and their management in old age. In: Brocklehurst's textbook of geriatric medicine and gerontology. 5th ed. New York, NY: Churchill Livingstone, 1998; 1247-1288
24. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
25. Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease: The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139:1435-1438
26. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 1999; 70:7-12
27. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38:955-962
28. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34:50s-59s
29. de Leeuw PW, Dees A. Fluid homeostasis in chronic obstructive lung disease. Eur Respir J Suppl 2003; 46:33s-40s
30. 2O handling in chronic obstructive lung disease. Arch Intern Med 1982; 142:1326-1330
31. Oren R, Beeri M, Hubert A, et al. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Arch Intern Med 1997; 157:1474-1478
32. Calverley PM, Leggett RJ, McElderry L, et al. Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale. Am Rev Respir Dis 1982; 125:507-510
33. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28:53-61
34. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103:792-802
35. Al Falluji N, Lawrence-Nelson J, Kostis JB, et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144:636-641
36. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-1060
37. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
38. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345:1230-1236
39. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37:1775-1780
40. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill; current clinical practice in the United States. Crit Care Med 2004; 32:39-52
41. Cappell MS, Nadler SC. Increased mortality of acute upper gastrointestinal bleeding in patients with chronic obstructive pulmonary disease: a case controlled, multiyear study of 53 consecutive patients. Dig Dis Sci 1995; 40:256-262